High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections

References

1. Calderone R. A, Fonzi W. A. 2001; Virulence factors of Candida albicans . Trends Microbiol 9:327–335 [CrossRef]
   [Google Scholar]
2. De Bernardis F, Chiani P, Ciccozzi M, Pellegrini G, Ceddia T, D'Offizzi G, Quinti I, Sullivan P. A, Cassone A. 1996; Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun 64:466–471
   [Google Scholar]
3. De Bernardis F, Arancia S, Morelli L, Hube B, Sanglard D, Schafer W, Cassone A. 1999; Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2 , are virulence factors for Candida vaginitis. J Infect Dis 179:201–208 [CrossRef]
   [Google Scholar]
4. De Bernardis F, Sullivan P. A, Cassone A. 2001; Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med Mycol 39:303–313 [CrossRef]
   [Google Scholar]
5. Ghannoum M. A. 2000; Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13:122–143 [CrossRef]
   [Google Scholar]
6. Hube B, Sanglard D, Odds F. C, Hess D, Monod M, Schafer W, Brown A. J, Gow N. A. 1997; Disruption of each of the secreted aspartyl proteinase genes SAP1 , SAP2 , and SAP3 of Candida albicans attenuates virulence. Infect Immun 65:3529–3538
   [Google Scholar]
7. Ibrahim A. S, Mirbod F, Filler S. G, Banno Y, Cole G. T, Kitajima Y, Edwards J. E Jr, Nozawa Y, Ghannoum M. A. 1995; Evidence implicating phospholipase as a virulence factor of Candida albicans . Infect Immun 63:1993–1998
   [Google Scholar]
8. Kantarcioglu A. S, Yucel A. 2002; Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 45:160–165 [CrossRef]
   [Google Scholar]
9. Kothavade R. J, Panthaki M. H. 1998; Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice. J Med Microbiol 47:99–102 [CrossRef]
   [Google Scholar]
10. Leidich S. D, Ibrahim A. S, Fu Y. 8 other authors 1998; Cloning and disruption of ca PLB1 , a phospholipase B gene involved in the pathogenicity of Candida albicans . J Biol Chem 273:26078–26086 [CrossRef]
    [Google Scholar]
11. Ollert M. W, Wende C, Gorlich M, McMullan-Vogel C. G, Borg-von Zepelin M, Vogel C. W, Korting H. C. 1995; Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol 33:2543–2549
    [Google Scholar]
12. Price M. F, Wilkinson I. D, Gentry L. O. 1982; Plate method for detection of phospholipase activity in Candida albicans . Sabouraudia 20:7–14 [CrossRef]
    [Google Scholar]
13. Samaranayake L. P, Raeside J. M, MacFarlane T. W. 1984; Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 22:201–207 [CrossRef]
    [Google Scholar]
14. Sanglard D, Hube B, Monod M, Odds F. C, Gow N. A. 1997; A triple deletion of the secreted aspartyl proteinase genes SAP4 , SAP5 , and SAP6 of Candida albicans causes attenuated virulence. Infect Immun 65:3539–3546
    [Google Scholar]
15. Watts H. J, Cheah F. S, Hube B, Sanglard D, Gow N. A. 1998; Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol Lett 159:129–135 [CrossRef]
    [Google Scholar]